Smoking Relapse-Prevention Intervention for Cancer Patients

H. Lee Moffitt Cancer Center and Research Institute441 enrolled

Overview

The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.

This study involves participation at four distinct time points over a one-year period. * Baseline assessment * 2-month follow-up telephone call * 6-month follow-up telephone call * 12-month follow-up telephone call

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

441

Conditions

Smoking Cessation

Interventions

Usual CareBEHAVIORAL

Standard care includes routine assessment of smoking behavior and brief clinical intervention. Smoking counseling for all participants in the current study will be completed by a Certified Tobacco Treatment Specialist consisting consists of brief counseling (\<15 minutes) based on the 5 A's Clinical Practice Guidelines; Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, Arrange for follow-up (Fiore et al., 2008). Patients receive information for local and state smoking resources (e.g., Quitline), pharmacotherapy options, and if interested, assistance with obtaining a prescription for pharmacotherapy. Follow-up with patients occurs at 2-weeks, only among those who are prescribed smoking medications (i.e., Varenicline, Bupropion).

Smoking Relapse Prevention for Cancer Patients (SRP-CaP)BEHAVIORAL

The proposed multimodal intervention consists of a series of easy-to-read relapse prevention booklets (Forever Free) that have shown to be efficacious with a general smoking population (Brandon et al., 2000; 2004), and digital video disk (DVD) customized to the needs of cancer patients (to be developed in Year One).

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Have smoked at least 10 cigarettes per day for at least one year prior to cancer diagnosis * Able to read and write English * Able to give informed consent * Have quit smoking after receiving their cancer diagnosis * Have not quit greater than 3 months prior Exclusion Criteria: * Individuals who have been abstinent for greater than 3 months are not included because they are less likely to relapse. A quit will be defined as self-reported no smoking for 24 hours. Individuals with metastatic disease will be excluded because participation in the study might be burdensome.

Locations (1)

H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, United States

Outcomes

Primary Outcomes

Number of Participants with Relapse at 6 Months

Number of participants with smoking relapse at 6 months follow-up for each treatment arm.

Time frame: 6 Months

Number of Participants with Relapse at 12 Months

Number of participants with smoking relapse at 12 months for each treatment arm.

Time frame: 12 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.